Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report released on Thursday morning. The brokerage issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Stock Up 2.0 %

RKDA opened at $3.89 on Thursday. Arcadia Biosciences has a 12-month low of $1.85 and a 12-month high of $10.31. The stock has a market cap of $5.30 million, a price-to-earnings ratio of -0.91 and a beta of 0.88. The business has a 50 day moving average of $5.10 and a 200-day moving average of $4.04.

Institutional Trading of Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC purchased a new position in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned about 0.90% of Arcadia Biosciences at the end of the most recent quarter. 17.73% of the stock is currently owned by hedge funds and other institutional investors.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.